Elevated Expression of CAV1 is Associated with Unfavorable Prognosis of Patients with Breast Cancer Who Undergo Surgery and Neoadjuvant Chemotherapy

Jia-Hui Ye,1 Jia-Jun Shi,1 Xi Yin,1 Hong-Yan Wu,2 Xin-Yun Xu,2 Yong-Zhong Yao,1 Wei-Jie Zhang1 1General Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, People’s Republic of China; 2Pathology Department, Nanjing Drum Towe...

Full description

Bibliographic Details
Main Authors: Ye JH, Shi JJ, Yin X, Wu HY, Xu XY, Yao YZ, Zhang WJ
Format: Article
Language:English
Published: Dove Medical Press 2020-09-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/elevated-expression-of-cav1-is-associated-with-unfavorable-prognosis-o-peer-reviewed-article-CMAR
_version_ 1818870140225191936
author Ye JH
Shi JJ
Yin X
Wu HY
Xu XY
Yao YZ
Zhang WJ
author_facet Ye JH
Shi JJ
Yin X
Wu HY
Xu XY
Yao YZ
Zhang WJ
author_sort Ye JH
collection DOAJ
description Jia-Hui Ye,1 Jia-Jun Shi,1 Xi Yin,1 Hong-Yan Wu,2 Xin-Yun Xu,2 Yong-Zhong Yao,1 Wei-Jie Zhang1 1General Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, People’s Republic of China; 2Pathology Department, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, People’s Republic of ChinaCorrespondence: Wei-Jie Zhang; Yong-Zhong Yao No. 321 Zhonshan Road, Nanjing, Jiangsu, People’s Republic of ChinaTel +86 13770773971Fax +86 25-83105896Email zhangweijie1616@163.com; loyal1006@hotmail.comIntroduction: Neoadjuvant chemotherapy (NACT), which is standard treatment for locally advanced breast cancer, improves the resectability of patients with early breast cancer and reduces the extent of breast and axillary surgery. Caveolin-1 (CAV1) is implicated in human cancers, although its utility for cancer prognosis is unknown. Here, we investigated the expression of CAV1 in breast cancer tissues to evaluate its prognostic significance on patients with breast cancer administered NACT.Methods: CAV1 expression in 80 breast cancer tissue samples was evaluated using immunohistochemistry (IHC). The association between CAV1 levels and clinical factors was analyzed using the chi-square test and that between CAV1 and prognosis was evaluated using multivariate Cox regression and Kaplan–Meier analyses.Results: High levels of CAV1 were significantly associated with survival, and patients with overexpression of CAV1 had a poor prognosis. Adjusted multivariate Cox regression analyses revealed that a high level of CAV1 expression was an independent, significant prognostic factor for patients with breast cancer treated with NACT.Discussion: Overexpression of CAV1 in patients with breast cancer administered NACT was associated with shorter disease-free survival and overall survival. Therefore, high levels of CAV1 may serve as a prognostic biomarker for such patients.Keywords: CAV1, IHC, clinical outcome, biomarker
first_indexed 2024-12-19T12:02:17Z
format Article
id doaj.art-b7cbcdcc863f429ea19ca61f7ba2b19b
institution Directory Open Access Journal
issn 1179-1322
language English
last_indexed 2024-12-19T12:02:17Z
publishDate 2020-09-01
publisher Dove Medical Press
record_format Article
series Cancer Management and Research
spelling doaj.art-b7cbcdcc863f429ea19ca61f7ba2b19b2022-12-21T20:22:28ZengDove Medical PressCancer Management and Research1179-13222020-09-01Volume 128887889257264Elevated Expression of CAV1 is Associated with Unfavorable Prognosis of Patients with Breast Cancer Who Undergo Surgery and Neoadjuvant ChemotherapyYe JHShi JJYin XWu HYXu XYYao YZZhang WJJia-Hui Ye,1 Jia-Jun Shi,1 Xi Yin,1 Hong-Yan Wu,2 Xin-Yun Xu,2 Yong-Zhong Yao,1 Wei-Jie Zhang1 1General Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, People’s Republic of China; 2Pathology Department, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, People’s Republic of ChinaCorrespondence: Wei-Jie Zhang; Yong-Zhong Yao No. 321 Zhonshan Road, Nanjing, Jiangsu, People’s Republic of ChinaTel +86 13770773971Fax +86 25-83105896Email zhangweijie1616@163.com; loyal1006@hotmail.comIntroduction: Neoadjuvant chemotherapy (NACT), which is standard treatment for locally advanced breast cancer, improves the resectability of patients with early breast cancer and reduces the extent of breast and axillary surgery. Caveolin-1 (CAV1) is implicated in human cancers, although its utility for cancer prognosis is unknown. Here, we investigated the expression of CAV1 in breast cancer tissues to evaluate its prognostic significance on patients with breast cancer administered NACT.Methods: CAV1 expression in 80 breast cancer tissue samples was evaluated using immunohistochemistry (IHC). The association between CAV1 levels and clinical factors was analyzed using the chi-square test and that between CAV1 and prognosis was evaluated using multivariate Cox regression and Kaplan–Meier analyses.Results: High levels of CAV1 were significantly associated with survival, and patients with overexpression of CAV1 had a poor prognosis. Adjusted multivariate Cox regression analyses revealed that a high level of CAV1 expression was an independent, significant prognostic factor for patients with breast cancer treated with NACT.Discussion: Overexpression of CAV1 in patients with breast cancer administered NACT was associated with shorter disease-free survival and overall survival. Therefore, high levels of CAV1 may serve as a prognostic biomarker for such patients.Keywords: CAV1, IHC, clinical outcome, biomarkerhttps://www.dovepress.com/elevated-expression-of-cav1-is-associated-with-unfavorable-prognosis-o-peer-reviewed-article-CMARcav1ihcclinical outcomebiomarker
spellingShingle Ye JH
Shi JJ
Yin X
Wu HY
Xu XY
Yao YZ
Zhang WJ
Elevated Expression of CAV1 is Associated with Unfavorable Prognosis of Patients with Breast Cancer Who Undergo Surgery and Neoadjuvant Chemotherapy
Cancer Management and Research
cav1
ihc
clinical outcome
biomarker
title Elevated Expression of CAV1 is Associated with Unfavorable Prognosis of Patients with Breast Cancer Who Undergo Surgery and Neoadjuvant Chemotherapy
title_full Elevated Expression of CAV1 is Associated with Unfavorable Prognosis of Patients with Breast Cancer Who Undergo Surgery and Neoadjuvant Chemotherapy
title_fullStr Elevated Expression of CAV1 is Associated with Unfavorable Prognosis of Patients with Breast Cancer Who Undergo Surgery and Neoadjuvant Chemotherapy
title_full_unstemmed Elevated Expression of CAV1 is Associated with Unfavorable Prognosis of Patients with Breast Cancer Who Undergo Surgery and Neoadjuvant Chemotherapy
title_short Elevated Expression of CAV1 is Associated with Unfavorable Prognosis of Patients with Breast Cancer Who Undergo Surgery and Neoadjuvant Chemotherapy
title_sort elevated expression of cav1 is associated with unfavorable prognosis of patients with breast cancer who undergo surgery and neoadjuvant chemotherapy
topic cav1
ihc
clinical outcome
biomarker
url https://www.dovepress.com/elevated-expression-of-cav1-is-associated-with-unfavorable-prognosis-o-peer-reviewed-article-CMAR
work_keys_str_mv AT yejh elevatedexpressionofcav1isassociatedwithunfavorableprognosisofpatientswithbreastcancerwhoundergosurgeryandneoadjuvantchemotherapy
AT shijj elevatedexpressionofcav1isassociatedwithunfavorableprognosisofpatientswithbreastcancerwhoundergosurgeryandneoadjuvantchemotherapy
AT yinx elevatedexpressionofcav1isassociatedwithunfavorableprognosisofpatientswithbreastcancerwhoundergosurgeryandneoadjuvantchemotherapy
AT wuhy elevatedexpressionofcav1isassociatedwithunfavorableprognosisofpatientswithbreastcancerwhoundergosurgeryandneoadjuvantchemotherapy
AT xuxy elevatedexpressionofcav1isassociatedwithunfavorableprognosisofpatientswithbreastcancerwhoundergosurgeryandneoadjuvantchemotherapy
AT yaoyz elevatedexpressionofcav1isassociatedwithunfavorableprognosisofpatientswithbreastcancerwhoundergosurgeryandneoadjuvantchemotherapy
AT zhangwj elevatedexpressionofcav1isassociatedwithunfavorableprognosisofpatientswithbreastcancerwhoundergosurgeryandneoadjuvantchemotherapy